@inproceedings{inproceedings, title  = {{The North Trent experience of the use of first line pembrolizumab in stage IIIB/IV non-small cell lung cancer}},

 publisher = {{Elsevier BV}},

 url = {{}},

 year = {{2019}},

 month = {{1}},

 author = {{Elmushraf R and Clinch H and Salawu A and Fisher P and Young R and Lee C and Danson S and Bates E and Hatton M and Low L and Das T et al}},

 doi = {{10.1016/s0169-5002(19)30145-x}},

 volume = {{127}},

 journal = {{Lung Cancer}},

 pages = {{S43-S43}},

 note = {{Accessed on 2025/01/03}}}